These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32529963)

  • 21. Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.
    Varadhachary A; Chatterjee D; Garza J; Garr RP; Foley C; Letkeman A; Dean J; Haug D; Breeze J; Traylor R; Malek A; Nath R; Linbeck L
    medRxiv; 2020 Aug; ():. PubMed ID: 32817976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing Vaccines in the Fight against COVID-19.
    Cheong KH
    Bioessays; 2020 Nov; 42(11):e2000234. PubMed ID: 32902869
    [No Abstract]   [Full Text] [Related]  

  • 24. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.
    Campione E; Cosio T; Rosa L; Lanna C; Di Girolamo S; Gaziano R; Valenti P; Bianchi L
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
    Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():970. PubMed ID: 32574258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin.
    Miotto M; Di Rienzo L; Bò L; Boffi A; Ruocco G; Milanetti E
    Front Mol Biosci; 2021; 8():607443. PubMed ID: 33659275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].
    García-Salido A
    An Pediatr (Engl Ed); 2020 Jul; 93(1):60.e1-60.e7. PubMed ID: 32439309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2.
    Madadlou A
    Eur J Pharmacol; 2020 Oct; 885():173499. PubMed ID: 32841639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
    Root-Bernstein R
    Bioessays; 2020 Nov; 42(11):e2000076. PubMed ID: 32869330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
    Chatterjee SK; Saha S; Munoz MNM
    Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
    Echeverría G; Guevara Á; Coloma J; Ruiz AM; Vasquez MM; Tejera E; de Waard JH
    Int J Infect Dis; 2021 Apr; 105():21-25. PubMed ID: 33582369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
    Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
    Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2020 Dec; 92(12):195-200. PubMed ID: 33720594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    Bwire GM; Njiro BJ; Mwakawanga DL; Sabas D; Sunguya BF
    J Med Virol; 2021 Mar; 93(3):1361-1369. PubMed ID: 33090535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactoferrin for the treatment of COVID-19 (Review).
    Wang Y; Wang P; Wang H; Luo Y; Wan L; Jiang M; Chu Y
    Exp Ther Med; 2020 Dec; 20(6):272. PubMed ID: 33199997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
    Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020).
    Kim DS; Rowland-Jones S; Gea-Mallorquí E
    Front Immunol; 2020; 11():571481. PubMed ID: 33362759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.